SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Techniclone (TCLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Terry D. who wrote (3408)2/10/2000 5:45:00 PM
From: AurumRabosa  Read Replies (1) of 3702
 
Terry, The Terrace posts seem to address a different question having to do with binding another company's therapeutic molecule to TCLN's Cotara. What I'm wondering is in the case of a diagnostic being attached to Cotara will it speed up the time to market or not? I would think that an imaging diagnostic would go through its trials much faster since there's no need to demonstrate efficacy but merely the need to show that this new imaging agent matches or exceeds present imaging techniques. I'll keep my eye out for any examples that may shed light on this question.

I think the patents are very valuable. Has anyone proposed a reasonable estimate of their value?

I'm still trying to read everything I can find on TCLN. I requested an investor info package from their web site a few weeks ago but have yet to receive it.

It seems the fate of TCLN hangs in their ability to scare up some serious coin in the next few months. If I read correctly the old management and directors have left and the big financial backers have made concessions and added more money, but, according to Dr Bonfiglio's recent web broadcast they only have 3 months worth of cash now. I sense that the financial viability of the firm is in question at this point. What's your take on funding?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News